Cargando…
Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and results in severe neurodegeneration and progressive cognitive decline. Neurotrophins are growth factors involved in the development and survival of neurons, but also in underlying mechanisms for memory formation such as hippo...
Autores principales: | Dahlström, Märta, Madjid, Nather, Nordvall, Gunnar, Halldin, Magnus M., Vazquez-Juarez, Erika, Lindskog, Maria, Sandin, Johan, Winblad, Bengt, Eriksdotter, Maria, Forsell, Pontus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391421/ https://www.ncbi.nlm.nih.gov/pubmed/34440640 http://dx.doi.org/10.3390/cells10081871 |
Ejemplares similares
-
Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?
por: Madjid, Nather, et al.
Publicado: (2023) -
Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease
por: Parrado Fernandez, Cristina, et al.
Publicado: (2023) -
The battle of Alzheimer’s Disease – the beginning of the future Unleashing the potential of academic discoveries
por: Lundkvist, Johan, et al.
Publicado: (2014) -
Identification of amino acid residues of nerve growth factor important for neurite outgrowth in human dorsal root ganglion neurons
por: Dahlström, Märta, et al.
Publicado: (2019) -
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
por: Nordvall, Gunnar, et al.
Publicado: (2023)